Sponsor Pipeline

EuroCityClinic LLC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07130032 Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And… Metastatic Non-small Cell Lung Cancer (NSCLC) Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Melanoma (1)
Get alerts when EuroCityClinic LLC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free